List of Tables
Table 1. Global Female Sexual Dysfunction Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Female Sexual Dysfunction Treatment Drug Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Female Sexual Dysfunction Treatment Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Female Sexual Dysfunction Treatment Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Female Sexual Dysfunction Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Female Sexual Dysfunction Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Product Type & Application
Table 12. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Female Sexual Dysfunction Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Sexual Dysfunction Treatment Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Female Sexual Dysfunction Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2019-2024)
Table 19. Global Female Sexual Dysfunction Treatment Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2025-2030)
Table 21. Global Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Female Sexual Dysfunction Treatment Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Female Sexual Dysfunction Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Table 53. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2025-2030)
Table 54. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Table 63. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2025-2030)
Table 64. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Female Sexual Dysfunction Treatment Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Pharmaceuticals Company Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Duchesnay Company Information
Table 81. Duchesnay Description and Business Overview
Table 82. Duchesnay Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Duchesnay Female Sexual Dysfunction Treatment Drug Product
Table 84. Duchesnay Recent Developments/Updates
Table 85. Sprout Pharmaceuticals Company Information
Table 86. Sprout Pharmaceuticals Description and Business Overview
Table 87. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 89. Sprout Pharmaceuticals Recent Developments/Updates
Table 90. Cosette Pharmaceuticals Company Information
Table 91. Cosette Pharmaceuticals Description and Business Overview
Table 92. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 94. Cosette Pharmaceuticals Recent Developments/Updates
Table 95. Lupin Company Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lupin Female Sexual Dysfunction Treatment Drug Product
Table 99. Lupin Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Female Sexual Dysfunction Treatment Drug Distributors List
Table 103. Female Sexual Dysfunction Treatment Drug Customers List
Table 104. Female Sexual Dysfunction Treatment Drug Market Trends
Table 105. Female Sexual Dysfunction Treatment Drug Market Drivers
Table 106. Female Sexual Dysfunction Treatment Drug Market Challenges
Table 107. Female Sexual Dysfunction Treatment Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Female Sexual Dysfunction Treatment Drug
Figure 2. Global Female Sexual Dysfunction Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Female Sexual Dysfunction Treatment Drug Market Share by Type: 2023 & 2030
Figure 4. Estrogen Therapy Product Picture
Figure 5. Ospemifene Product Picture
Figure 6. Flibanserin Product Picture
Figure 7. Bremelanotide Product Picture
Figure 8. Others Product Picture
Figure 9. Global Female Sexual Dysfunction Treatment Drug Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Female Sexual Dysfunction Treatment Drug Market Share by Application: 2023 & 2030
Figure 11. Hospital Pharmacies
Figure 12. Private Clinics
Figure 13. Retail Pharmacies
Figure 14. E-Commerce (B2B)
Figure 15. E-Commerce (B2C)
Figure 16. Global Female Sexual Dysfunction Treatment Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Female Sexual Dysfunction Treatment Drug Market Size (2019-2030) & (US$ Million)
Figure 18. Global Female Sexual Dysfunction Treatment Drug Sales (2019-2030) & (K Units)
Figure 19. Global Female Sexual Dysfunction Treatment Drug Average Price (US$/Unit) & (2019-2030)
Figure 20. Female Sexual Dysfunction Treatment Drug Report Years Considered
Figure 21. Female Sexual Dysfunction Treatment Drug Sales Share by Manufacturers in 2023
Figure 22. Global Female Sexual Dysfunction Treatment Drug Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Female Sexual Dysfunction Treatment Drug Players: Market Share by Revenue in Female Sexual Dysfunction Treatment Drug in 2023
Figure 24. Female Sexual Dysfunction Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Female Sexual Dysfunction Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 27. North America Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 28. United States Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 31. Europe Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 32. Germany Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2019-2030)
Figure 39. China Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 47. Mexico Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Female Sexual Dysfunction Treatment Drug by Type (2019-2030)
Figure 57. Global Revenue Market Share of Female Sexual Dysfunction Treatment Drug by Type (2019-2030)
Figure 58. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Female Sexual Dysfunction Treatment Drug by Application (2019-2030)
Figure 60. Global Revenue Market Share of Female Sexual Dysfunction Treatment Drug by Application (2019-2030)
Figure 61. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2019-2030)
Figure 62. Female Sexual Dysfunction Treatment Drug Value Chain
Figure 63. Female Sexual Dysfunction Treatment Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
